Delirium, an acute neuropsychiatric syndrome, affects approximately 1 out of 3 older patients admitted to the hospital and is associated with poor outcomes, including increased rates of postdischarge institutionalization, cognitive decline and mortality. Approximately 20 to 25% of the patients who experience delirium dies within 6 to 12 months. Despite the high prevalence and clinical impact, very little is known about the underlying pathogenesis.
In this thesis, we have investigated potential novel biomarkers of delirium and the role of pharmacological agents in the development of delirium. The findings may contribute to a better understanding of the pathophysiology and may help to improve the prediction, detection and treatment of this syndrome.

Additional Metadata
Keywords Delirium, older persons, aging, hospital, biomarkers, drugs, medication, pathophysiology, pharmacology, cognitive decline
Promotor J.L.C.M. van Saase (Jan) , F.U.S. Mattace Raso (Francesco)
Publisher Erasmus University Rotterdam
ISBN 978-94-6361-059-9
Persistent URL hdl.handle.net/1765/104723
Note For copyright reasons there is a partial embargo for this dissertation
Citation
Egberts, A. (2018, March 7). Delirium in Old Age : Pathophysiological and Pharmacological Aspects. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/104723


Additional Files
Cover-image.PNG Cover Image , 215kb
Complete-version-thesis-A.Egberts.pdf Final Version , 1mb
Imposed Embargo until:
Fri, March 01 2019 at 00:00 (CET)
Propositions-A.-Egberts.pdf , 406kb